Cerebral venous thrombosis in a patient with Down syndrome and coronavirus disease 2019: a case report

Background The new coronavirus disease 2019 pandemic has spread throughout most of the world. Cerebral venous thrombosis is a rare thromboembolic disease that can present as an extrapulmonary complication in coronavirus disease 2019 infection. Case presentation We report the case of a Hispanic woman...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medical case reports 2021-07, Vol.15 (1), p.1-364, Article 364
Main Authors: Robayo-Amortegui, Henry, Valenzuela-Faccini, Natalia, Quecano-Rosas, Cesar, Zabala-Muéoz, Darlyng, Perez-Garzon, Michel
Format: Article
Language:English
Subjects:
Anticoagulants
Case Report
Case reports
Cerebral venous thrombosis
Coagulopathy
Convulsions & seizures
Coronaviruses
COVID-19
Disease transmission
Down syndrome
Epidemics
Epidemiology
Epilepsy
Health aspects
Hispanic American women
Immunoglobulins
Infection
Infections
Intensive care
Levetiracetam
Magnetic resonance imaging
Mortality
Neuroinfection diseases
Neurological complications
Patients
Performance evaluation
Risk factors
Severe acute respiratory syndrome coronavirus 2
Sinuses
Thromboembolism
Thrombophlebitis
Thrombosis
Ventilators
Viral infections
Womens health
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The new coronavirus disease 2019 pandemic has spread throughout most of the world. Cerebral venous thrombosis is a rare thromboembolic disease that can present as an extrapulmonary complication in coronavirus disease 2019 infection. Case presentation We report the case of a Hispanic woman with Down syndrome who has coronavirus disease 2019 and presents as a complication extensive cerebral venous thrombosis. Conclusions Cerebral venous thrombosis is a rare thromboembolic disease that can present as an extrapulmonary complication in coronavirus disease 2019 infection. In the absence of clinical and epidemiological data, it is important to carry out further investigation of the risk factors and pathophysiological causes related to the development of cerebrovascular thrombotic events in patients with Down syndrome with coronavirus disease 2019 infection. Keywords: Down syndrome, COVID-19, Cerebral venous thrombosis, Coagulopathy, Neuroinfection diseases, Neurological complications
ISSN:1752-1947
1752-1947
DOI:10.1186/s13256-021-02908-0